Trial Profile
The first clinical trial of BC-821 as a cancer therapy
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 21 Feb 2022
Price :
$35
*
At a glance
- Drugs BC 821 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 10 Nov 2015 New trial record
- 06 Nov 2015 The company is planning to initiate this trial in 2016, according to a BioCancell media release.